AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published June 12, 2008

American Journal of Neuroradiology 2008;29:1505.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1121v1
29/8/1505    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirai, T.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirai, T.
Right arrow Articles by Yamashita, Y.

American Journal of Neuroradiology
DOI 10.3174/ajnr.A1121

BRAIN

Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study

T. Hirai, R. Murakami, H. Nakamura, M. Kitajima, H. Fukuoka, A. Sasao, M. Akter, Y. Hayashida, R. Toya, N. Oya, K. Awai, K. Iyama, J.-i. Kuratsu and Y. Yamashita

From the Departments of Diagnostic Radiology (T.H., M.K., H.F., A.S., M.A., Y.H., K.A., Y.Y.), Radiation Oncology (R.M., R.T., N.O.), Neurosurgery (H.N., J.-i.K.), and Pathology (K.I.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Please address correspondence to Toshinori Hirai, MD, Department Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan; e-mail: t-hirai{at}kumamoto-u.ac.jp

BACKGROUND AND PURPOSE: Although the prognostic value of perfusion MR imaging in various gliomas has been investigated, that in high-grade astrocytomas alone has not been fully evaluated. The purpose of this study was to evaluate retrospectively whether the tumor maximum relative cerebral blood volume (rCBV) on pretreatment perfusion MR imaging is of prognostic value in patients with high-grade astrocytoma.

MATERIALS AND METHODS: Between January 1999 and December 2002, 49 patients (30 men, 19 women; age range, 23–76 years) with supratentorial high-grade astrocytoma underwent MR imaging before the inception of treatment. The patient age, sex, symptom duration, neurologic function, mental status, Karnofsky Performance Scale, extent of surgery, histopathologic diagnosis, tumor component enhancement, and maximum rCBV were assessed to identify factors affecting survival. Kaplan-Meier survival curves, the logrank test, and the multivariate Cox proportional hazards model were used to evaluate prognostic factors.

RESULTS: The maximum rCBV was significantly higher in the 31 patients with glioblastoma multiforme than in the 18 with anaplastic astrocytoma (P < .03). The 2-year overall survival rate was 67% for 27 patients with a low (≤2.3) and 9% for 22 patients with a high (>2.3) maximum rCBV value (P < .001). Independent important prognostic factors were the histologic diagnosis (hazard ratio = 9.707; 95% confidence interval (CI), 3.163–29.788), maximum rCBV (4.739; 95% CI, 1.950–11.518), extent of surgery (2.692; 95% CI, 1.196–6.061), and sex (2.632; 95% CI, 1.153–6.010).

CONCLUSION: The maximum rCBV at pretreatment perfusion MR imaging is a useful clinical prognostic biomarker for survival in patients with high-grade astrocytoma.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
S.C. Feldman, D. Chu, M. Schulder, M. Barry, E.-S. Cho, and W.-C. Liu
The Blood Oxygen Level-Dependent Functional MR Imaging Signal Can Be Used to Identify Brain Tumors and Distinguish Them from Normal Tissue
AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 389 - 395.
[Abstract] [Full Text] [PDF]


Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X